A family owned, global leading Australian joint health company that specialises in the research and development of an advanced range of proprietary, clinically proven products. Interpath brings together patented, premium quality, natural ingredients with the latest in molecular and cellular biology techniques to create products that work towards repairing and restoring damaged joints as well as actively maintaining joint health. Interpath’s signature product range – powered by EPIITALIS® and developed for both humans and animals – represents a medical-breakthrough in the treatment and prevention of joint injury and degenerative diseases such as osteoarthritis and osteoporosis.